A 52-week open-label study to investigate tolerability of rivastigmine switching from oral capsule to transdermal patch in mild to moderate Alzheimer’s disease patients in Taiwan
2017
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI